News
TMC is delighted to announce a successful, validated clinical trial submission using the new EU Clinical Trial Information System (CTIS) on behalf
TMC Pharma is delighted to announce we will be attending World Orphan Drug Congress on 23rd – 25th My 2023 in Washington
TMC Pharma Services, the international pharmaceutical development organisation that specialises in innovative treatments for rare diseases, is part of a news-style programme
As of 1 January 2022, “combined review” is the way all new Clinical Trials of an Investigational Medicinal Product (CTIMP) applications must
We’re supporting the Rare Diseases campaign from Mediaplanet. Please see our article https://bit.ly/3j94tAm Learn more about the challenges, and the future for Rare
TMC Pharma Services has received confirmation from the Medicines and Healthcare products Regulatory Agency (MHRA) that our recent application, made on behalf